ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Previous studies have identified significant variability in attention-deficit / hyperactivity disorder (ADHD) prevalence estimates worldwide, largely explained by methodological procedures. However, increasing rates of ADHD diagnosis and treatment throughout the past few decades have fuelled concerns about whether the true prevalence of the disorder has increased over time. METHODS: We updated the two most comprehensive systematic reviews on ADHD prevalence available in the literature. Meta-regression analyses were conducted to test the effect of year of study in the context of both methodological variables that determined variability in ADHD prevalence (diagnostic criteria, impairment criterion and source of information), and the geographical location of studies. RESULTS: We identified 154 original studies and included 135 in the multivariate analysis. Methodological procedures investigated were significantly associated with heterogeneity of studies. Geographical location and year of study were not associated with variability in ADHD prevalence estimates. CONCLUSIONS: Confirming previous findings, variability in ADHD prevalence estimates is mostly explained by methodological characteristics of the studies. In the past three decades, there has been no evidence to suggest an increase in the number of children in the community who meet criteria for ADHD when standardized diagnostic procedures are followed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“After adjusting for these factors, a subsequent meta-analysis concluded that the prevalence of ADHD does not significantly differ between countries in Europe, Asia, Africa and the Americas, as well as in Australia 3 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, even within communities there is marked variability in rates of ADHD due to the subjective nature of primarily descriptive (symptom-based) diagnostic procedures (Asherson et al., 2012; Polanczyk et al., 2014; see also recent reports by the US Center for Disease Control and Prevention).”
From Functional neuroimaging of visuospatial working memory tasks enables accurate detection of attention deficit and hyperactivity disorder (2015) · cites this paper as Polanczyk et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous research in children and adolescents has identified higher prevalence estimates based on research diagnosis via DSM-validated scales, compared to the prevalence based on the ICD-9 or ICD-10 diagnostic criteria (Polanczyk et al., 2007;Polanczyk et al., 2014), commonly used in register-based studies.”
From Prevalence of attention-deficit/hyperactivity disorder in older adults: a systematic review and meta-analysis (2020) · cites this paper as Polanczyk et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ADHD occurs throughout the developed and developing world”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Polanczyk et al., 2014
The cited source says what the claim attributes to it.
In the citing paper
“Another meta-analysis, with 135 studies and about a quarter of a million youths, found no significant differences in prevalence between North America and Europe, Asia, Africa, South America, and Oceania”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Polanczyk et al., 2014
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464 · cited 2×
“The ‘variance accounted for’ (VAF), a pseudo-R2 statistic, is given for each univariate model, indicating the percentage of the total heterogeneity in the true effects (heterogeneity) that is accounted for by each study-level variable (moderator) individually.(12) We also calculated the VAF for the model with all cova…”
MethodThe worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Self-citationNature-nurture reconceptualized in developmental perspective: A bioecological model.
Bronfenbrenner, U., & Ceci, S. J. (1994) · Psychological Review · doi:10.1037/0033-295x.101.4.568 · Cited by 2,973
Outlier and influence diagnostics for meta-analysis
Viechtbauer, W., & Cheung, M. W.-L. (2010) · Research Synthesis Methods · doi:10.1002/jrsm.11 · Cited by 2,949 · cited 1×
“Outlier and influential case diagnostics were performed using the externally standardized residuals, DFFITS values, Cook’s distances, covariance ratios, leave-one-out estimates of the amount of heterogeneity, leave-one-out heterogeneity test statistics, hat values and weights.(13) The analysis and graphical presentati…”
MethodGlobal Prevalence of Autism and Other Pervasive Developmental Disorders
Elsabbagh, M., Divan, G., Koh, Y., Kim, Y. S., Kauchali, S., Marcín, C., Montiel‐Nava, C., Patel, V., Paula, C. S., Wang, C., et al. (2012) · Autism Research · doi:10.1002/aur.239 · Cited by 2,636
The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
Willcutt, E. G. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0135-8 · Cited by 2,160 · cited 1×
“Further results detected significant heterogeneity between estimates, but once again country or region where the study was conducted did not explain the variability, supporting previous findings.(7) In addition, this study also did not address the effect of time on estimates.”
ResultSelf-citationEpidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971 · cited 1×
“awareness and access to medical services may explain the increasing rates over time.(10) However, the possibility that a true increase in the incidence of ASD and also in ADHD”
BackgroundAttention-deficit hyperactivity disorder
Biederman, J., & Faraone, S. V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66915-2 · Cited by 1,463
Attention-deficit hyperactivity disorder and hyperkinetic disorder
Swanson, J., Sergeant, J., Taylor, E., Sonuga-Barke, E., Jensen, P., & Cantwell, D. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11450-7 · Cited by 601
Attention-deficit hyperactivity disorder and hyperkinetic disorder
Swanson, J. M., Sergeant, J. A., Taylor, E., Sonuga-Barke, E. J. S., Jensen, P. S., & Cantwell, D. P. (2001) · Attention Deficit Hyperactivity Disorders · doi:10.4324/9781315054315-2 · Cited by 572
Cited by
Items 401–500 of 1,004
Kazda, L., McGeechan, K., Bell, K., Thomas, R., & Barratt, A. L. (2022) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13700 · Cited by 36
“The parent-report of behaviours may also have had an effect on our results, overestimating the proportion of children with clinical-range behaviours, as parents may report higher prevalence than clinicians (Polanczyk et al., 2014).”
BackgroundResultInfluentialLee, M., Lai, H., Kuo, Y., & Chen, V. C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101634 · Cited by 33
“Attention-deficit/hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder among children and adolescents, with an estimated prevalence rate of approximately 3% to 10% globally [1].”
BackgroundWunderli, M. D., Vonmoos, M., Niedecker, S. M., Hulka, L. M., Preller, K. H., Baumgartner, M. R., Kræmer, T., Seifritz, E., Schaub, M. P., Eich‐Höchli, D., et al. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.03.026 · Cited by 33
“Attention-deficit/hyperactivity disorder (ADHD) is another major public health issue (Ballon et al., 2015), with an estimated worldwide prevalence of about 5% in children (Polanczyk et al., 2014) and symptoms that persist into adulthood in up to 65% of patients (Faraone et al., 2006).”
BackgroundChen, Y., Chen, Y., & Gau, S. S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.023 · Cited by 34
Custodio, R. J. P., Botanas, C. J., de la Peña, J. B., Peña, I. J. D., Kim, M., Sayson, L. V., Abiero, A., Ryoo, Z. Y., Kim, B.-N., Kim, H. J., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.08.008 · Cited by 31
Clayton, K., Lee, J. B., Cheung, K., Theule, J., & Henrikson, B. (2018) · Child Abuse Review · doi:10.1002/car.2530 · Cited by 37
Medin, T., Medin, H., Hefte, M. B., Storm‐Mathisen, J., & Bergersen, L. H. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.023 · Cited by 30
“Attention-deficit/hyperactivity disorder (ADHD) is a common psychiatric condition [1] recognized by three main symptoms: inattention and/or hyperactivity and impulsivity [2].”
BackgroundHemamy, M., Heidari‐Beni, M., Askari, G., Karahmadi, M., & Maracy, M. R. (2020) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_546_17 · Cited by 34
“[1] The estimated prevalence of ADHD is between 5% and 7% in schoolchildren worldwide.[2,3] In Iran, its prevalence is 5.”
Kwon, S. J., Kim, Y., & Kwak, Y. (2020) · Journal of American College Health · doi:10.1080/07448481.2020.1740228 · Cited by 43
“Attention-deficit hyperactivity disorder (ADHD) involves inattention, impulsivity, and hyperactivity as its main symptoms,(1) and has become increasingly more prevalent over the past several decades.(2) ADHD is a major childhood psychologic disorder, but interest in adult ADHD is increasing, as it appears that the dis…”
BackgroundSlaby, I., Hain, H. S., Abrams, D. J., Mentch, F. D., Glessner, J., Abou‐Sleiman, P. M., & Hakonarson, H. H. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-022-09447-9 · Cited by 30
“Introduction ADHD is the most prevalent neurodevelopmental disorder in children [1, 2].”
BackgroundPsychological and cortisol reactivity to experimentally induced stress in adults with ADHD
Raz, S., & Leykin, D. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.05.008 · Cited by 42
“…Disorder (ADHD) is a common neuropsychiatric disorder affecting 3—7% of children, frequently persisting into adulthood (Akinbami et al., 2011; Bell, 2011; Faraone et al., 2003; Kessler et al., 2005, 2006; Polanczyk et al., 2014; Simon et al., 2009; Willcutt, 2012; Wolraich et al., 2012).”
Raising attention to attention deficit hyperactivity disorder in schizophrenia
Pallanti, S., & Salerno, L. (2015) · World Journal of Psychiatry · doi:10.5498/wjp.v5.i1.47 · Cited by 31
Brandt, L., & Fischer, G. (2019) · Journal of Attention Disorders · doi:10.1177/1087054717690232 · Cited by 27
Türk, S., Korfmacher, A.-K., Gerger, H., der Oord, S. V., & Christiansen, H. (2023) · Clinical Psychology Review · doi:10.1016/j.cpr.2023.102271 · Cited by 37
Sociodemographic disparities in ADHD diagnosis and treatment among U.S. elementary schoolchildren
Morgan, P. L., & Hu, E. H. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115393 · Cited by 34
Family Functioning in Children With ADHD and Subthreshold ADHD: A 3-Year Longitudinal Study
Bhide, S., Efron, D., Ukoumunne, O. C., Anderson, V. A., Nicholson, J. M., Silk, T. J., Hazell, P., Gülenç, A., & Sciberras, E. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231217089 · Cited by 42
“Attention-Deficit/Hyperactivity disorder (ADHD) is characterized by a pervasive pattern of inattention, hyperactivity and impulsivity symptoms and affects between 5 and 7% of children worldwide (Polanczyk et al., 2014).”
BackgroundZheng, Y., Pingault, J., Unger, J. B., & Rijsdijk, F. V. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01346-0 · Cited by 33
Kita, Y., Ashizawa, F., & Inagaki, M. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12950 · Cited by 35
Christiansen, M. S., Labriola, M., Kirkeskov, L., & Lund, T. (2021) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-021-00386-2 · Cited by 41
“[15], the prevalence of ADHD among children and adolescents (0–18 years) has more than tripled from 2006 to 2016, resulting in 25,029 children and adolescents diagnosed with ADHD in 2016.”
BackgroundLundin, C., Wikman, A., Wikman, P., Kallner, H. K., Poromaa, I. S., & Skoglund, C. B. (2022) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2022.07.847 · Cited by 34
Gray matter volume and microRNA levels in patients with attention-deficit/hyperactivity disorder
Wang, L., Li, S., Kuo, H., Chou, W., Lee, M., Chou, M., Tseng, H., Hsu, C.-F., Lee, S.-Y., & Lin, W. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01032-x · Cited by 32
“This disorder affects 3–10% of school-age children around the world [2], and a local prevalence rate of 7.”
BackgroundHyde, C. E., Sciberras, E., Efron, D., Fuelscher, I. T., & Silk, T. J. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00280-z · Cited by 34
McCarthy, S. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s42145 · Cited by 36
“It is reported that the prevalence of ADHD in children globally is approximately 5%.(5,6) There is now consensus among experts that ADHD may currently affect at least 1%–2% of adults in the UK and 2%–4% worldwide.”
BackgroundVuori, M. A., Koski-Pirilä, A., Martikainen, J. E., & Saastamoinen, L. (2020) · Scandinavian Journal of Public Health · doi:10.1177/1403494820901426 · Cited by 40
Morkem, R., Handelman, K., Queenan, J. A., Birtwhistle, R., & Barber, D. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01182-2 · Cited by 37
“due to changes in diagnostic criteria, education policies and increasing awareness and access to medical services [23, 24].”
BackgroundNew Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
Pitzianti, M. B., Spiridigliozzi, S., Bartolucci, E., Esposito, S., & Pasini, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.531092 · Cited by 28
Sphingolipid and Endocannabinoid Profiles in Adult Attention Deficit Hyperactivity Disorder
Brunkhorst-Kanaan, N., Trautmann, S., Schreiber, Y., Thomas, D., Kittel‐Schneider, S., Gurke, R., Geißlinger, G., Reif, A., & Tegeder, I. (2021) · Biomedicines · doi:10.3390/biomedicines9091173 · Cited by 32
“It is a multifactorial trait in which genetic factors account for about 75% of the phenotypic variance, and environmental factors, including premature birth, perinatal hypoxia, maternal smoking or alcohol, were suggested to contribute to the remaining 25% [2,3].”
BackgroundCheng, S., Coghill, D., & Zendarski, N. J. (2022) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2022.104180 · Cited by 37
Battison, E., Brown, P. C. M., Holley, A. L., & Wilson, A. C. (2023) · Children · doi:10.3390/children10010142 · Cited by 37
“Prevalence estimates of ADHD vary depending on country and study methodology, but it affects approximately 3–4% of children and adolescents worldwide [13,14].”
BackgroundResultCunha, F., Campos, S., Simões-Silva, V., Brugada-Ramentol, V., Sá‐Moura, B., Jalali, H., Bozorgzadeh, A., & Trigueiro, M. J. (2023) · Frontiers in Virtual Reality · doi:10.3389/frvir.2023.1108060 · Cited by 33
Bonati, M. R., Reale, L., Zanetti, M., Cartabia, M., Fortinguerra, F., Capovilla, G., Chiappedi, M. A., Costantino, M. A., Effedri, P., Luoni, C., et al. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715599573 · Cited by 30
ADHD and Academic Performance in College Students: A Systematic Review
Pagespetit, È., Pagerols, M., Barrés, N., Prat, R., Martínez, L., Andreu, M., Prat, G., Casas, M., & Bosch, R. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241306554 · Cited by 50
“It is mostly diagnosed during childhood with a prevalence around 5.29% (Polanczyk et al., 2014).”
InfluentialVerlaet, A. A. J., Ceulemans, B., Verhelst, H., West, D. V., Bruyne, T. D., Pieters, L. A. C., Savelkoul, H. F. J., & Hermans, N. (2017) · Trials · doi:10.1186/s13063-017-1879-6 · Cited by 36
“such as oppositional defiant disorder (ODD), autism and anxiety [2, 3].”
BackgroundPrescription Psychostimulant Use Among Young Adults: A Narrative Review of Qualitative Studies
Robitaille, C., & Collin, J. (2016) · Substance Use & Misuse · doi:10.3109/10826084.2015.1110170 · Cited by 38
Jahangard, L., Akbarian, S., Haghighi, M., Ahmadpanah, M., Keshavarzi, A., Bajoghli, H., Bahmani, D. S., Holsboer‐Trachsler, E., & Brand, S. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.12.010 · Cited by 34
Carpena, M. X., Hutz, M. H., Salatino‐Oliveira, A., Polanczyk, G. V., Zeni, C., Schmitz, M. D., Chazan, R., Genro, J. P., Rohde, L. A., & Tovo‐Rodrigues, L. (2019) · Genes · doi:10.3390/genes10020088 · Cited by 32
“Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopment disorders during childhood and adolescence, affecting ~5% of people at this age worldwide [1].”
BackgroundSelf-citationPredictors of Health-Related Quality of Life in Neurodivergent Children: A Systematic Review
Mahjoob, M., Paul, T., Carbone, J., Bokadia, H., Cardy, R. E., Kassam, S., Anagnostou, E. A., Andrade, B. F., Penner, M., & Kushki, A. (2023) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-023-00462-3 · Cited by 35
“…autism spectrum disorder (autism 1 ; prevalence 1 in 66; Ofner et al., 2018), attention-deficit/hyperactivity disorder (ADHD; prevalence 1 in 20; Polanczyk et al., 2014), intellectual disability (ID; prevalence up to 63 in 1000), communication disorders (prevalence up to 1 in 10), learning…”
BackgroundDepression and severity of substance dependence among heroin dependent patients with ADHD symptoms
Liao, Y., Chen, C.-Y., Ng, M., Huang, K., Shao, W., Lin, T., Chen, V. C., & Gossop, M. (2016) · American Journal on Addictions · doi:10.1111/ajad.12487 · Cited by 29
“1% as defined by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition in a review and a meta-analysis.(2,3) ADHDwas believed to be a childhood disorder but it has been found that 40–60% of childhood ADHD persists into adulthood.”
BackgroundHolden, J. T., Kaburakis, A., & Tweedie, J. W. (2018) · Sport Ethics and Philosophy · doi:10.1080/17511321.2018.1459814 · Cited by 26
“…with this style of doping, using drugs that are commonly prescribed for one of the more prominent ailments in society (Faraone et al. 2003; Polanczyk et al. 2014, 2007; Rowland et al. 2018), is that there is a risk of either abuse of the TUE system or excluding too many competitors who…”
MethodJanmohammadi, S., Haghgoo, H. A., Farahbod, M., Overton, P. G., & Pishyareh, E. (2020) · Journal of Eye Movement Research · doi:10.16910/jemr.12.8.6 · Cited by 31
Knott, R., Johnson, B. P., Tiego, J., Mellahn, O. J., Finlay, A., Kallady, K., Kouspos, M., Sindhu, V. P. M., Hawi, Z., Arnatkevičiūtė, A., et al. (2021) · Molecular Autism · doi:10.1186/s13229-021-00457-3 · Cited by 29
Role of Nutrition and Diet on Healthy Mental State
Granero, R. (2022) · Nutrients · doi:10.3390/nu14040750 · Cited by 31
“The disorder is usually diagnosed when a child is of school age, with a worldwide prevalence estimate of 6% during childhood [4], and persistent into adulthood with a mean rate of 43% (estimates between adults is around 3% within population-based samples) [5].”
BackgroundKlomjai, W., Siripornpanich, V., Aneksan, B., Vimolratana, O., Permpoonputtana, K., Tretriluxana, J., & Thichanpiang, P. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.02.032 · Cited by 32
School attendance problems in adolescent with attention deficit hyperactivity disorder
Niemi, S., Lagerström, M., & Alanko, K. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.1017619 · Cited by 45
Giacobini, M., Ahnemark, E., Medin, E., Freilich, J., Andersson, M., Ma, Y., & Ginsberg, Y. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231177221 · Cited by 35
“, 2019), affecting around 5% to 7% of children/adolescents and 2% to 3% of adults worldwide (Elliott et al., 2020; Faraone et al., 2021; Polanczyk et al., 2014; Polyzoi et al., 2018; Thomas et al., 2015).”
BackgroundTaylor, M. J., Martin, J., Butwicka, A., Lichtenstein, P., D'Onofrio, B. M., Lundström, S., Larsson, H., & Rosenqvist, M. A. (2023) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13854 · Cited by 29
Fast, K., Wentz, E., Roswall, J., Strandberg, M., Bergman, S., & Dahlgren, J. (2023) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15757 · Cited by 29
Suchert, V., Pedersen, A., Hanewinkel, R., & Isensee, B. (2017) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-017-0229-6 · Cited by 34
“ADHD is one of the most prevalent mental disorders among children and adolescents (Thapar and Cooper 2016; Thomas et al. 2015; Polanczyk et al. 2014), and especially, symptoms of inattention are likely to persist into adulthood (Wilens et al. 2004).”
BackgroundForslund, T., Peltola, M. J., & Brocki, K. C. (2019) · Attachment & Human Development · doi:10.1080/14616734.2019.1664603 · Cited by 41
McCarthy, S., Neubert, A., Man, K. K. C., Banaschewski, T., Buitelaar, J., Carucci, S., Coghill, D., Danckaerts, M., Falissard, B., Garas, P., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1884-7 · Cited by 25
“The worldwide prevalence of ADHD among school-aged children and adolescents is around 5% [2, 3].”
BackgroundHammer, R., Cooke, G. E., Stein, M. A., & Booth, J. R. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.08.015 · Cited by 25
“…and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA eDepartment of Communication Sciences and Disorders, The University of Texas at Austin, Austin, TX, USA * Corresponding author at: Department of Communi Northwestern University, 2240 Campus Drive, Eva Tel.”
BackgroundPelsser, L., Frankena, K., Toorman, J., & Rodrigues Pereira, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00096 · Cited by 25
ADHD and later-life labor market outcomes in the United States
Rietveld, C. A., & Patel, P. C. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-019-01055-0 · Cited by 29
Cross-Country Differences in Parental Reporting of Symptoms of ADHD
MacDonald, B., Pennington, B. F., Willcutt, E. G., Dmitrieva, J., Samuelsson, S., Byrne, B., & Olson, R. K. (2019) · Journal of Cross-Cultural Psychology · doi:10.1177/0022022119852422 · Cited by 32
“In addition, similar results from many other community samples across countries indicate that the country differences in mean symptom levels of ADHD are not due to a selection artifact, especially since the difference persists regardless of the behavioral rating measure used (Crijnen et al., 1999; Faraone, Sergeant, G…”
MethodResultSelf-citationBlanco-Martínez, N., Delgado‐Lobete, L., Montes‐Montes, R., Ruiz-Pérez, N., Ruiz-Pérez, M., & Santos-del-Riego, S. (2020) · Children · doi:10.3390/children7100157 · Cited by 33
“5% of children had a lifetime diagnosis of ADHD worldwide during the past three decades [7], while this prevalence ranges between 4.”
BackgroundADHD misdiagnosis: Causes and mitigators
Furzer, J., Dhuey, E., & Laporte, A. (2022) · Health Economics · doi:10.1002/hec.4555 · Cited by 41
Prevalence of severe ADHD: an epidemiological study in the Italian regions of Tuscany and Latium
Donfrancesco, R., Marano, A., Calderoni, D., Mugnaini, D., Thomas, F., Trani, M. D., Innocenzi, M., & Vitiello, B. (2014) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796014000523 · Cited by 31
“The prevalence of ADHD is estimated to be about 5% worldwide, but with a large variability that is mainly attributed to differences in diagnostic and ascertainment methods (Polanczyk et al. 2007, 2014).”
BackgroundMethodErlandsson, S., Lundin, L., & Punzi, E. H. (2016) · International Journal of Qualitative Studies on Health and Well-Being · doi:10.3402/qhw.v11.30938 · Cited by 30
“There has been an escalation of biomedical understanding of children’s behavioral and emotional problems and a subsequent increase of drug prescriptions for such behaviors (e.g., Polanczyk et al., 2014).”
BackgroundZhao, X., Rangaprakash, D., Yuan, B., Denney, T. S., Katz, J. S., Dretsch, M. N., & Deshpande, G. (2018) · Frontiers in Applied Mathematics and Statistics · doi:10.3389/fams.2018.00025 · Cited by 28
“This condition affects about 5% of children and adolescents worldwide [ 16].”
BackgroundThe Influence of Generalized Anxiety Disorder on Executive Functions in Children with ADHD
Menghini, D., Armando, M., Calcagni, M., Napolitano, C., Pasqualetti, P., Sergeant, J. A., Pani, P., & Vicari, S. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0831-9 · Cited by 23
Kóbor, A., Takács, Á., Bryce, D., Szűcs, D., Honbolygó, F., Nagy, P., & Csépe, V. (2015) · Developmental Neuropsychology · doi:10.1080/87565641.2015.1086770 · Cited by 28
Farnia, V., Gharehbaghi, H., Alikhani, M., Almasi, A., Golshani, S., Tatari, F., Davarinejad, O., Salemi, S., Bahmani, D. S., Holsboer‐Trachsler, E., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.07.008 · Cited by 28
Akmatov, M. K., Steffen, A., Holstiege, J., Hering, R., Schulz, M., & Bätzing, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-35048-5 · Cited by 29
Wang, L., Lee, S.-Y., Chou, M., Lee, M., & Chou, W. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.01.025 · Cited by 24
Andrés, M. I. F., Tejero, P., & Vélez‐Calvo, X. (2019) · Journal of Attention Disorders · doi:10.1177/1087054719864637 · Cited by 34
Approach to Evaluating and Managing Adult Attention-Deficit/Hyperactivity Disorder in Primary Care
Huang, H. Y., Huang, H., Spottswood, M., & Ghaemi, S. N. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000248 · Cited by 27
Context Regulation of Mind Wandering in ADHD
Bozhilova, N. S., Michelini, G., Jones, C., Kuntsi, J., Rubia, K., & Asherson, P. J. (2020) · Journal of Attention Disorders · doi:10.1177/1087054720956714 · Cited by 32
“ADHD is a common neurodevelopmental disorder affecting 5% to 7% of children (Sayal et al., 2018; Polanczyk et al., 2014).”
BackgroundMykletun, A., Widding‐Havneraas, T., Chaulagain, A., Lyhmann, I., Bjelland, I., Halmøy, A., Elwert, F., Butterworth, P., Markussen, S., Zachrisson, H. D., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041698 · Cited by 30
Keenan, L., Sherlock, C., Bramham, J., & Downes, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.03.018 · Cited by 31
“ADHD is characterised by inattention, hyperactivity, and/or impulsivity (Thapar and Cooper, 2016) and has an estimated worldwide prevalence rate of approximately 5% (Polanczyk et al., 2007, 2014).”
BackgroundDupuy, C., Castelnau, P., Mavel, S., Lefèvre, A., Nadal‐Desbarats, L., Bodard, S., Busson, J., Dufour‐Rainfray, D., Blasco, H., Emond, P., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01344-4 · Cited by 27
Roberts, D. K., Alderson, R. M., Betancourt, J. L., & Bullard, C. C. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102039 · Cited by 28
Rönö, K., Rissanen, E., Bergh, C., Wennerholm, U., Opdahl, S., Romundstad, L. B., Henningsen, A.-K. A., Spangmose, A. L., Pinborg, A. B., Gissler, M., et al. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.01.010 · Cited by 34
Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders
Efron, D., & Taylor, K. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20085430 · Cited by 38
“Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder, with a prevalence of approximately 5% [46].”
BackgroundLow serum sphingolipids in children with attention deficit-hyperactivity disorder
Henríquez‐Henríquez, M., Solari, S., Quiroga, T., Kim, B. I., Deckelbaum, R. J., & Worgall, T. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00300 · Cited by 30
Sensation Seeking and Cocaine Dependence in Adults With Reported Childhood ADHD
Ballon, N., Brunault, P., & Cortese, S. (2014) · Journal of Attention Disorders · doi:10.1177/1087054714543651 · Cited by 27
Kanazawa, O. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.09.078 · Cited by 31
“Recently, the prevalence of developmental disorders, especially ADHD and ASD, has been increasing worldwide [3–5].”
BackgroundAttention-deficit hyperactivity disorder in adults with epilepsy
Ashjazadeh, N., Sahraeian, A., Sabzgolin, I., & Asadi‐Pooya, A. A. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106543 · Cited by 24
Chen, C., Sun, S., Chen, R., Guo, Z., Tang, X., Chen, G., Chen, P., Tang, G., Huang, L., & Wang, Y. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111199 · Cited by 30
Coutinho, T. V., Reis, S. P. S., da Silva, A. G., de Miranda, D. M., & Malloy‐Diniz, L. F. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00299 · Cited by 36
“Eur Child Adolesc Psychiatry (2014) 23(5):257–71.”
BackgroundInfluentialImmediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Cândido, R. C. F., de Padua, C. A. M., Golder, S., & Junqueira, D. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013011.pub2 · Cited by 44
“Nevertheless, prevalence rates of ADHD in children have remained stable in the last 30 years (Polanczyk 2014).”
BackgroundInfluentialTaylor, A., Novo, D., & Foreman, D. M. (2019) · Healthcare · doi:10.3390/healthcare7030102 · Cited by 38
“Systematic review and meta-analysis data estimate the prevalence to be between 5 and 7% [1,2].”
The Development and Usability of a Mobile App for Parents of Children with ADHD
Poetar, C.-R., Kertesz, R., & Dobrean, A. (2023) · Children · doi:10.3390/children10010164 · Cited by 29
“Attention-deficit/hyperactivity disorder (ADHD) is a prevalent mental health problem in children, with an estimated worldwide prevalence around 5% [1].”
BackgroundMassat, I., Slama, H., Villemonteix, T., Mary, A., Baijot, S., Albajara Sáenz, A., Balériaux, D., Metens, T., Kavec, M., & Peigneux, P. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1237040 · Cited by 23
“Attention deficit-hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders (estimated worldwide-pooled prevalence >5%), and is characterised by symptoms of inattention and/or hyperactivity/impulsivity, which commonly persists into adulthood (Polanczyk et al. 2014).”
BackgroundIntegrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
Pagerols, M., Richarte, V., Sánchez‐Mora, C., Rovira, P., Artigas, M. S., Iris Garcia-martinez, A., Calvo-Sánchez, E., Corrales, M., da Silva, B. S., Mota, N. R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20194-7 · Cited by 27
Self-citationModels of attention-deficit hyperactivity disorder
Killeen, P. R. (2019) · Behavioural Processes · doi:10.1016/j.beproc.2019.01.001 · Cited by 29
Mutations in sphingolipid metabolism genes are associated with ADHD
Henríquez‐Henríquez, M., Acosta, M. T., Martinez, A. F., Velez, J. I., Lopera, F. J., Pineda, D. A., Palacio, J. D., Quiroga, T., Worgall, T. S., Deckelbaum, R. J., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00881-8 · Cited by 28
Holingue, C., Volk, H. E., Crocetti, D., Gottlieb, B., Spira, A. P., & Mostofsky, S. H. (2021) · Sleep Health · doi:10.1016/j.sleh.2020.12.006 · Cited by 29
Hai, T., Swansburg, R. M., MacMaster, F. P., & Lemay, J.-F. (2021) · Frontiers in Education · doi:10.3389/feduc.2021.614181 · Cited by 24
“Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder with prevalence rates between 5% and 9% in Canadian school-aged children (Brault and Lacourse, 2012; Polanczyk et al., 2014).”
BackgroundMerikangas, K. R. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.03.002 · Cited by 25
Preliminary evidence for a lower brain age in children with attention-deficit/hyperactivity disorder
Kurth, F., Levitt, J. G., Gaser, C., Alger, J. R., Loo, S. K., Narr, K. L., O’Neill, J., & Luders, E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1019546 · Cited by 25
Willis, R., Dhakras, S., & Cortese, S. (2017) · Current Developmental Disorders Reports · doi:10.1007/s40474-017-0116-z · Cited by 31
“The rest of the studies reported the prevalence of ADHD in LAC (without comparison to a non-LAC group), which was substantially higher than the national prevalence of ADHD in the study country [25].”
BackgroundDifferential Efficacy of Neurofeedback in Children with ADHD Presentations
Cueli, M., Rodríguez, C., Cabaleiro, P., García, T., & Castro, P. G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020204 · Cited by 25
“Given the symptomatology of ADHD and its high prevalence rates [4,5], it is important for researchers to analyze the efficacy of the different treatments and interventions aimed at inattention, hyperactivity, and impulsivity, such as medication, neurofeedback, and behavioral treatments.”
BackgroundDekkers, T. J., Huizenga, H. M., Bult, J., Popma, A., & Boyer, B. E. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-020-01579-4 · Cited by 29
Ocular findings in children with attention deficit hyperactivity disorder: A Case–Control study
Ababneh, L. T., Bashtawi, M. A., Ababneh, B. F., Mahmoud, I. H., Rashdan, M., & Zahran, M. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.08.005 · Cited by 28
Ercan, E. S., Ünsel‐Bolat, G., Tufan, A. E., Demirkaya, S. K., Bılaç, Ö., Çelik, G. G., Kılıç, B. G., Ardıç, Ü. A., Sapmaz, Ş. Y., Aksu, H., et al. (2021) · Journal of Attention Disorders · doi:10.1177/10870547211017985 · Cited by 37
Gutiérrez-Casares, J. R., Quintero, J., Jorba, G., Junet, V., Martínez, V., Pozo-Rubio, T., Oliva, B., Daura, X., Mas, J. M., & Montoto, C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.741170 · Cited by 28
Galéra, C., Cortese, S., Orri, M., Collet, O. A., van der Waerden, J. E. B., Melchior, M., Boivin, M., Tremblay, R. E., & Côté, S. M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01357-x · Cited by 23
Dekkers, T. J., Hornstra, R., van den Hoofdakker, B. J., de Jong, S. R. C., Schaaf, J. V., Bosmans, G., & van der Oord, S. (2021) · Brain Sciences · doi:10.3390/brainsci11111516 · Cited by 21
“In children, the prevalence of ADHD is high, with 5–7% of children meeting diagnostic criteria [2,3].”
BackgroundThe Role of Comorbid Symptoms in Perceived Stress and Sleep Problems in Adolescent ADHD
Frick, M. A., Meyer, J., & Isaksson, J. (2022) · Child Psychiatry & Human Development · doi:10.1007/s10578-022-01320-z · Cited by 31
“ADHD is one of the most prevalent psychiatric conditions, affecting 5–7% of children and adolescents worldwide [6] and is characterized by elevated and disabling symptoms of inattention and hyperactivity/impulsivity [7].”
BackgroundPaediatric asthma and non‐allergic comorbidities: A review of current risk and proposed mechanisms
Brew, B. K., Osvald, E. C., Gong, T., Hedman, A. M., Holmberg, K., Larsson, H., Ludvigsson, J. F., Mubanga, M., Smew, A. I., & Almqvist, C. (2022) · Clinical & Experimental Allergy · doi:10.1111/cea.14207 · Cited by 26
Metadata
- Authors
- Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A.
- Affiliations
- Universidade Federal do Rio Grande do Sul (BR)
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-24
- Volume
- 43
- Issue
- 2
- Pages
- 434-442
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- PMC
- PMC4817588
- OpenAlex
- W2127901933
- Semantic Scholar
- 49eed63a8f5e937ec836d62f79aeeb8cd9c33805
- Cited by
- 1,822
- References
- 28
- Citations by year
- 2026: 137 · 2025: 184 · 2024: 168 · 2023: 188 · 2022: 184 · 2021: 170 · 2020: 180 · 2019: 140 · 2018: 154 · 2017: 111 · 2016: 102 · 2015: 76 · 2014: 24
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH063941, R01MH062120)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD068728, R01HD047264)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- attention deficit hyperactivity disorder, ADHD prevalence, temporal trends, diagnostic criteria, information sources, methodological heterogeneity, children, community prevalence
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Epidemiologic Methods, Humans, Time Factors, Global Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.